Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
MAMSTR - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
CD93 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
FAM189A1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SLC8A1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
DLK1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TDH - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
LYST - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
HAVCR1P1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SERPINA1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CELF1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SEPT10 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
EMCN - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MRGPRX4 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LOC102724352 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LINC00959 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CX3CR1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MIOS - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LOC100505904 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on